Predicting response to immunotherapy plus chemotherapy in patients with esophageal squamous cell carcinoma using non-invasive Radiomic biomarkers

OBJECTIVES: To develop and validate a radiomics model for evaluating treatment response to immune-checkpoint inhibitor plus chemotherapy (ICI + CT) in patients with advanced esophageal squamous cell carcinoma (ESCC). METHODS: A total of 64 patients with advance ESCC receiving first-line ICI + CT at...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Ying, Yao, Wang, Xu, Bing-Chen, Lei, Yi-Yan, Guo, Qi-Kun, Liu, Li-Zhi, Li, Hao-Jiang, Xu, Min, Yan, Jing, Chang, Dan-Dan, Feng, Shi-Ting, Zhu, Zhi-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557514/
https://www.ncbi.nlm.nih.gov/pubmed/34717582
http://dx.doi.org/10.1186/s12885-021-08899-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557514/
https://www.ncbi.nlm.nih.gov/pubmed/34717582
http://dx.doi.org/10.1186/s12885-021-08899-x

Ejemplares similares